CHANGES  ||| S:0 E:8 ||| NNS
IN  ||| S:8 E:11 ||| IN
GLUTATHIONE  ||| S:11 E:23 ||| NNP
SYSTEM  ||| S:23 E:30 ||| NNP
AND  ||| S:30 E:34 ||| CC
LIPID  ||| S:34 E:40 ||| NNP
PEROXIDATION  ||| S:40 E:53 ||| NNP
IN  ||| S:53 E:56 ||| IN
RAT  ||| S:56 E:60 ||| NNP
BLOOD  ||| S:60 E:66 ||| NNP
DURING  ||| S:66 E:73 ||| NNP
THE  ||| S:73 E:77 ||| NNP
FIRST  ||| S:77 E:83 ||| NNP
HOUR  ||| S:83 E:88 ||| NNP
AFTER  ||| S:88 E:94 ||| NNP
CHLORPYRIFOS  ||| S:94 E:107 ||| NNP
EXPOSURE  ||| S:107 E:116 ||| NNP
Chlorpyrifos  ||| S:116 E:129 ||| NNP
( ||| S:129 E:130 ||| -LRB-
CPF ||| S:130 E:133 ||| NNP
)  ||| S:133 E:135 ||| -RRB-
is  ||| S:135 E:138 ||| VBZ
a  ||| S:138 E:140 ||| DT
highly  ||| S:140 E:147 ||| RB
toxic  ||| S:147 E:153 ||| JJ
organophosphate  ||| S:153 E:169 ||| JJ
compound ||| S:169 E:177 ||| NN
,  ||| S:177 E:179 ||| ,
widely  ||| S:179 E:186 ||| RB
used  ||| S:186 E:191 ||| VBN
as  ||| S:191 E:194 ||| IN
an  ||| S:194 E:197 ||| DT
active  ||| S:197 E:204 ||| JJ
substance  ||| S:204 E:214 ||| NN
of  ||| S:214 E:217 ||| IN
many  ||| S:217 E:222 ||| JJ
insecticides ||| S:222 E:234 ||| NN
.  ||| S:234 E:236 ||| .
Along  ||| S:236 E:242 ||| RB
with  ||| S:242 E:247 ||| IN
the  ||| S:247 E:251 ||| DT
anticholinesterase  ||| S:251 E:270 ||| JJ
action ||| S:270 E:276 ||| NN
,  ||| S:276 E:278 ||| ,
CPF  ||| S:278 E:282 ||| NNP
may  ||| S:282 E:286 ||| MD
affect  ||| S:286 E:293 ||| VB
other  ||| S:293 E:299 ||| JJ
biochemical  ||| S:299 E:311 ||| JJ
mechanisms ||| S:311 E:321 ||| NNS
,  ||| S:321 E:323 ||| ,
particularly  ||| S:323 E:336 ||| RB
through  ||| S:336 E:344 ||| IN
disrupting  ||| S:344 E:355 ||| VBG
pro-  ||| S:355 E:360 ||| JJ
and  ||| S:360 E:364 ||| CC
antioxidant  ||| S:364 E:376 ||| JJ
balance  ||| S:376 E:384 ||| NN
and  ||| S:384 E:388 ||| CC
inducing  ||| S:388 E:397 ||| VBG
free-radical  ||| S:397 E:410 ||| JJ
oxidative  ||| S:410 E:420 ||| JJ
stress ||| S:420 E:426 ||| NN
.  ||| S:426 E:428 ||| .
Origins  ||| S:428 E:436 ||| NNP
and  ||| S:436 E:440 ||| CC
occurrence  ||| S:440 E:451 ||| NN
of  ||| S:451 E:454 ||| IN
these  ||| S:454 E:460 ||| DT
phenomena  ||| S:460 E:470 ||| NNS
are  ||| S:470 E:474 ||| VBP
still  ||| S:474 E:480 ||| RB
not  ||| S:480 E:484 ||| RB
fully  ||| S:484 E:490 ||| RB
understood ||| S:490 E:500 ||| VBN
.  ||| S:500 E:502 ||| .
The  ||| S:502 E:506 ||| DT
aim  ||| S:506 E:510 ||| NN
of  ||| S:510 E:513 ||| IN
our  ||| S:513 E:517 ||| PRP$
work  ||| S:517 E:522 ||| NN
was  ||| S:522 E:526 ||| VBD
to  ||| S:526 E:529 ||| TO
investigate  ||| S:529 E:541 ||| VB
the  ||| S:541 E:545 ||| DT
effects  ||| S:545 E:553 ||| NNS
of  ||| S:553 E:556 ||| IN
chlorpyrifos  ||| S:556 E:569 ||| NN
on  ||| S:569 E:572 ||| IN
key  ||| S:572 E:576 ||| JJ
parameters  ||| S:576 E:587 ||| NNS
of  ||| S:587 E:590 ||| IN
glutathione  ||| S:590 E:602 ||| JJ
system  ||| S:602 E:609 ||| NN
and  ||| S:609 E:613 ||| CC
on  ||| S:613 E:616 ||| IN
lipid  ||| S:616 E:622 ||| JJ
peroxidation  ||| S:622 E:635 ||| NN
in  ||| S:635 E:638 ||| IN
rat  ||| S:638 E:642 ||| JJ
blood  ||| S:642 E:648 ||| NN
in  ||| S:648 E:651 ||| IN
the  ||| S:651 E:655 ||| DT
time  ||| S:655 E:660 ||| NN
dynamics  ||| S:660 E:669 ||| NNS
during  ||| S:669 E:676 ||| IN
one  ||| S:676 E:680 ||| CD
hour  ||| S:680 E:685 ||| NN
after  ||| S:685 E:691 ||| IN
exposure ||| S:691 E:699 ||| NN
.  ||| S:699 E:701 ||| .
We  ||| S:701 E:704 ||| PRP
found  ||| S:704 E:710 ||| VBD
that  ||| S:710 E:715 ||| IN
a  ||| S:715 E:717 ||| DT
single  ||| S:717 E:724 ||| JJ
exposure  ||| S:724 E:733 ||| NN
to  ||| S:733 E:736 ||| TO
50  ||| S:736 E:739 ||| CD
mg ||| S:739 E:741 ||| CD
/ ||| S:741 E:742 ||| CD
kg  ||| S:742 E:745 ||| NNS
chlorpyrifos  ||| S:745 E:758 ||| VBP
caused  ||| S:758 E:765 ||| VBN
a  ||| S:765 E:767 ||| DT
linear  ||| S:767 E:774 ||| JJ
decrease  ||| S:774 E:783 ||| NN
in  ||| S:783 E:786 ||| IN
butyryl  ||| S:786 E:794 ||| JJ
cholinesterase  ||| S:794 E:809 ||| JJ
activity ||| S:809 E:817 ||| NN
,  ||| S:817 E:819 ||| ,
increased  ||| S:819 E:829 ||| VBN
activity  ||| S:829 E:838 ||| NN
of  ||| S:838 E:841 ||| IN
glutathione  ||| S:841 E:853 ||| JJ
peroxidase  ||| S:853 E:864 ||| NN
and  ||| S:864 E:868 ||| CC
glutathione  ||| S:868 E:880 ||| JJ
reductase ||| S:880 E:889 ||| NN
,  ||| S:889 E:891 ||| ,
alterations  ||| S:891 E:903 ||| VBG
in  ||| S:903 E:906 ||| IN
the  ||| S:906 E:910 ||| DT
levels  ||| S:910 E:917 ||| NNS
of  ||| S:917 E:920 ||| IN
glutathione ||| S:920 E:931 ||| NN
,  ||| S:931 E:933 ||| ,
TBA-active  ||| S:933 E:944 ||| JJ
products  ||| S:944 E:953 ||| NNS
and  ||| S:953 E:957 ||| CC
lipid  ||| S:957 E:963 ||| JJ
hydroperoxides  ||| S:963 E:978 ||| NN
during  ||| S:978 E:985 ||| IN
1  ||| S:985 E:987 ||| CD
hour  ||| S:987 E:992 ||| NN
after  ||| S:992 E:998 ||| IN
poisoning ||| S:998 E:1007 ||| NN
.  ||| S:1007 E:1009 ||| .
The  ||| S:1009 E:1013 ||| DT
most  ||| S:1013 E:1018 ||| RBS
significant  ||| S:1018 E:1030 ||| JJ
changes  ||| S:1030 E:1038 ||| NNS
in  ||| S:1038 E:1041 ||| IN
studied  ||| S:1041 E:1049 ||| JJ
parameters  ||| S:1049 E:1060 ||| NNS
were  ||| S:1060 E:1065 ||| VBD
detected  ||| S:1065 E:1074 ||| VBN
at  ||| S:1074 E:1077 ||| IN
the  ||| S:1077 E:1081 ||| DT
15-30th  ||| S:1081 E:1089 ||| CD
minutes  ||| S:1089 E:1097 ||| NNS
after  ||| S:1097 E:1103 ||| IN
chlorpyrifos  ||| S:1103 E:1116 ||| JJ
exposure ||| S:1116 E:1124 ||| NN
.  ||| S:1124 E:1126 ||| .
